Tumor News and Research

RSS
Study reveals how MMSET gene enables disease-causing mutations to occur

Study reveals how MMSET gene enables disease-causing mutations to occur

Metamark announces Nature journal published landmark prostate cancer study results

Metamark announces Nature journal published landmark prostate cancer study results

Researchers to develop new diagnostics platform for early detection of lung cancer

Researchers to develop new diagnostics platform for early detection of lung cancer

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

Agilent introduces first commercial RNA target enrichment system

Agilent introduces first commercial RNA target enrichment system

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Four-gene/protein signature more accurately predicts metastatic prostate cancer

Scientists challenged to sequence genome and RNA content derived from single cancer cell

Scientists challenged to sequence genome and RNA content derived from single cancer cell

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

Five young scientists receive Damon Runyon-Rachleff Innovation Award for cancer research

Five young scientists receive Damon Runyon-Rachleff Innovation Award for cancer research

Elsevier acquires Cancer Information Group's oncology journals portfolio

Elsevier acquires Cancer Information Group's oncology journals portfolio

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Aphios enters subcontract with SAIC-Frederick to develop phospholipid nanoencapsulated camptothecin

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

New robotic technique can better predict tumors during radiotherapy, prevent severity of side effects

New robotic technique can better predict tumors during radiotherapy, prevent severity of side effects

Researchers find better way to create iPS cells from blood samples

Researchers find better way to create iPS cells from blood samples

Study finds treatment-related mortality with bevacizumab in cancer patients

Study finds treatment-related mortality with bevacizumab in cancer patients

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Bioengineers and physician-scientists zap tumors with light-activated nanoparticles

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

Scientists discover breast cancer cells that dodge immune system, promote tumor growth

EA sponsors research grant to investigate specific cancers and kinase mutations

EA sponsors research grant to investigate specific cancers and kinase mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.